Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEuMelaReg gGmbH
About this trial
This current registry study will analyze real-world data to address questions about disease characteristics and treatment patterns in NMSC patients based on the European NMSC-Registry. The overall objective is to describe characteristics, management and treatment outcomes for patients presenting with advanced NMSC (cSCC/BCC) or HR-cSCC in routine clinical practice, independent of treatments used across different European regions.
Eligibility criteria
Qualifiers
Patients aged ≥18 years at index date
Patients documented in the European NMSC-registry fulfilling EMR quality standard
Patients with resected HR-cSCC (Cohort 1) receiving only postoperative radiotherapy or watchful waiting OR Patients with advanced cSCC who are not candidates for curative surgery/radiation in routine clinical practice (Cohort 2) OR Patients with advanced BCC who are not candidates for curative surgery/radiation in routine clinical practice (Cohort 3)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,300 Participants
are grouped into 3 trial groupsSponsors and collaborators
Source ClinicalTrials.gov